Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity-Related Hypertension: An Emerging Clinical Phenotype.

The American journal of cardiology·2026
Same author

Non-invasive versus invasive estimation of left ventricular wall stress with cardiac magnetic resonance imaging in severe aortic stenosis.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance·2025
Same author

Five-year outcomes of the early-generation Intrepid transapical transcatheter mitral valve replacement system.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2025
Same author

Percutaneous Femoral Arterial Closure Following Decannulation of Venoarterial Extracorporeal Membrane Oxygenation Using the MANTA Vascular Closure Device.

Heart, lung & circulation·2025
Same author

30-Day and 1-Year Outcomes of Navitor Transcatheter Aortic Valve in Low- or Intermediate-Risk Patients.

JACC. Cardiovascular interventions·2025
Same author

Relationship between left ventricular wall stress and cardiac remodelling post-TAVR and MitraClip.

Open heart·2025

Related Experiment Video

Updated: May 8, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Renal denervation: current implications and future perspectives.

Jianzhong Xu1, Dagmara Hering, Yusuke Sata

  • 1*Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia.

Clinical Science (London, England : 1979)
|September 12, 2013
PubMed
Summary
This summary is machine-generated.

Sympathetic nervous system (SNS) overactivity drives hypertension. Renal denervation offers a promising interventional approach for blood pressure control in resistant hypertension.

More Related Videos

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

Related Experiment Videos

Last Updated: May 8, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Interventional Cardiology

Background:

  • Sympathetic nervous system (SNS) activation is integral to arterial hypertension development and progression.
  • SNS overactivity correlates with various conditions like chronic renal failure, insulin resistance, and heart failure.
  • Pharmacological sympatholytic agents are underutilized, leaving SNS overactivity largely unaddressed in many patients.

Purpose of the Study:

  • To review the physiological role of renal nerves in hypertension and related diseases.
  • To summarize current clinical data on the safety and efficacy of renal denervation for resistant hypertension.
  • To discuss future implications and emerging devices for renal denervation.

Main Methods:

  • Review of existing literature on renal nerve physiology and hypertension.
  • Analysis of clinical studies evaluating catheter-based renal denervation.
  • Discussion of preliminary data from uncontrolled studies and ongoing trials.

Main Results:

  • Renal denervation demonstrates a clinically relevant blood pressure reduction in resistant hypertension patients.
  • The procedure exhibits a favorable vascular and renal safety profile.
  • Preliminary data in SNS-overactive disease states are promising but require further validation.

Conclusions:

  • Renal denervation is a viable therapeutic option for resistant hypertension by modulating renal nerve traffic.
  • Further well-designed clinical trials are necessary to confirm the efficacy and expand the application of renal denervation.
  • Newer devices are under investigation to optimize blood pressure control through renal denervation.